Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
22.29
-0.51 (-2.24%)
At close: Jul 20, 2026, 4:00 PM EDT
22.19
-0.10 (-0.47%)
After-hours: Jul 20, 2026, 7:34 PM EDT
Syndax Pharmaceuticals Market Cap
Syndax Pharmaceuticals has a market cap or net worth of $1.98 billion as of July 20, 2026. Its market cap has increased by 142.64% in one year.
Market Cap
1.98B
Enterprise Value
1.96B
1-Year Change
142.64%
Ranking
Category
Stock Price
$22.29
ChartMarket Cap Chart
Since March 3, 2016, Syndax Pharmaceuticals's market cap has increased from $208.60M to $1.98B, an increase of 846.84%. That is a compound annual growth rate of 24.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 1.98B | 8.16% |
| Dec 31, 2025 | 1.83B | 61.83% |
| Dec 31, 2024 | 1.13B | -25.02% |
| Dec 29, 2023 | 1.50B | -1.81% |
| Dec 30, 2022 | 1.53B | 41.76% |
| Dec 31, 2021 | 1.08B | 18.96% |
| Dec 31, 2020 | 908.90M | 281.41% |
| Dec 31, 2019 | 238.30M | 115.66% |
| Dec 31, 2018 | 110.50M | -48.29% |
| Dec 29, 2017 | 213.70M | 63.88% |
| Dec 30, 2016 | 130.40M | -37.49% |
| Mar 3, 2016 | 208.60M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Monte Rosa Therapeutics | 2.07B |
| Aurinia Pharmaceuticals | 2.05B |
| Rapport Therapeutics | 2.04B |
| Nuvation Bio | 2.02B |
| ADMA Biologics | 2.02B |
| Viridian Therapeutics | 1.99B |
| AbCellera Biologics | 1.97B |
| GH Research | 1.97B |